FdaApplication
ANDA 207325
Identifiers
- fda_app_no: ANDA207325
Properties
| Property | Value |
|---|---|
| applicant_name | GLAND PHARMA LTD |
| application_type | ANDA |
| approval_date | 2017-02-10 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS |
| OXALIPLATIN | OXALIPLATIN | 200MG/40ML (5MG/ML) | INJECTABLE;INTRAVENOUS |
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS |
3 products